JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 2502
CAS [1207456-01-6]
MF C19H14F2N6OMW 380.35
Potent, selective, and orally available PARP1/2 inhibitor (IC50 value 0.57 nM for PARP1) that shows antitumor cytotoxicity with 20- to more than 200-fold greater potency than earlier-generation PARP1/2 inhibitors and with selectivity for tumor cells with BRCA1, BRCA2, or PTEN gene defects.
KEYWORDS: Talazoparib | PARP inhibitor | Axon 2502 | BMN 673 | LT 00673 | BMN673 | LT00673 | CAS [1207456-01-6] | DNA-RNA | PARP | Inhibitor | BRCA1 | BRCA2 | PTEN | gene defects
(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one
[1207456-01-6]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
Download the Axon Ligands™ catalogue 2021 Spring Edition
* Required Fields